P65-047

N/A

Report date: 2025/12/12 15:28:36
NME

Base Information

Drug NameP65-047
Drug Alias NameP65-047
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTranscriptional enhancer factor degraders
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBeactica Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesBeactica Therapeutics AB
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A